Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
Abstract Background Amivantamab is a monoclonal bispecific anti-EGFR-MET antibody used to treat non-small cell lung cancer. There were no published methods using a liquid chromatographic—tandem mass spectrometric approach to develop and validate a feasible, novel, and thoroughly validated method for...
में बचाया:
| मुख्य लेखकों: | , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SpringerOpen
2024-04-01
|
| श्रृंखला: | Future Journal of Pharmaceutical Sciences |
| विषय: | |
| ऑनलाइन पहुंच: | https://doi.org/10.1186/s43094-024-00629-x |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|